You just read:

BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination With Anti-PD-1 for the Treatment of Any Type of Cancer

News provided by

BioLineRx Ltd.

Feb 27, 2020, 07:43 ET